Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy

17 Sept 2018

Abstract excerpt

Aldehyde dehydrogenase (ALDH) activity is commonly used as a marker to identify cancer stem-like cells. The three ALDH1A isoforms have all been individually implicated in cancer stem-like cells and in chemoresistance; however, which isoform is preferentially expressed varies between cell lines. We sought to explore the structural determinants of ALDH1A isoform selectivity in a series of small-molecule inhibitors...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Lung Cancer Research Studies
Share to Polyamine Metabolism and Applications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30221940
DOI: 10.1021/acs.jmedchem.8b00930

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer ChemotherapyPMID 30221940Read ↗

A novel ALDH1A1 inhibitor blocks platinum-induced senescence and stemness in ovarian cancerSemantic proximity Read ↗

A novel ALDH1A1 Inhibitor Blocks Platinum-Induced Senescence and Stemness in Ovarian CancerSemantic proximity Read ↗

Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian CancerSemantic proximity Read ↗

ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signaling.Semantic proximity Read ↗

The Expanding Role of Cancer Stem Cell Marker ALDH1A3 in Cancer and BeyondSemantic proximity Read ↗

The Concept of Cancer Stem Cells: Elaborating on ALDH1B1 as an Emerging Marker of Cancer ProgressionSemantic proximity Read ↗

Targeting Aldehyde Dehydrogenases to Eliminate Cancer Stem Cells in Gynecologic MalignanciesSemantic proximity Read ↗

Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial CancersSemantic proximity Read ↗

A Selective Competitive Inhibitor of Aldehyde Dehydrogenase 1A3 Hinders Cancer Cell Growth, Invasiveness and Stemness In VitroSemantic proximity Read ↗

Phenotypic High-Throughput Screening Elucidates Target Pathway in Breast Cancer Stem Cell–Like CellsSemantic proximity Read ↗

ALDH1A1 in breast cancer: A prospective target to overcome therapy resistance (Review)Semantic proximity Read ↗

Aldehyde dehydrogenase 1A1 in stem cells and cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.